OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Targeting the Primary Tumor in Metastatic Pancreatic Cancer 2026

A Step Toward Standardized Biomarker Testing in Cancer Care - NCCN

10 Must-Read Posts on Cellular Immunotherapy This Week

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

National Cancer Centers of Japan and Singapore Collaborate to Advance Cancer Care Across Asia

Oncology News, Insights, Stories by OncoDaily

Ryan Schoenfeld
Voices

Ryan Schoenfeld: How Our Understanding of Cancer Cachexia Is Evolving

Gedatolisib
Breast Oncology

Gedatolisib Enters ER+ Breast Cancer Care, But the Real Question Is How to Use It

Robin Zon
Voices

Robin Zon: How ASCO and State Affiliates Are Improving Access to Quality Cancer Care

CAR-T Therapy: Biology, Mechanisms, Clinical Success, and Future Directions

NIH Launches New Funding Opportunity to Advance AI Research Infrastructure

GLOBOCAN 2024: Looking Beyond the Numbers to Understand Global Cancer Disparities

10 Must-Read Posts In GU Oncology This Week

Miriam Mutebi: The Power of Community Along the Breast Cancer Journey

Naoto Ueno: Advancing Oncology Drug Development in Japan at J-HOPE

BTS at W Korea’s Breast Cancer Gala: Why the Event Sparked Global Backlash

Voices
Jame Abraham

Jame Abraham: Congratulations to Dana Angelini on Receiving the Clinical Excellence Award

Gregory Lesinski: Winship Team Publishes Novel CAR/VIPRa T-Cell Therapy in Science

Bishal Gyawali: Dealing With Grief and Loss After the Death of Patients

Advancing Targeted Therapies for Rare Cancers - Servier

Bartolomeo Rossi Completes Pediatric Oncology Residency Through the M2ICOS Project - ESO

From Research to Real-World Impact: Advancing the Future of Cancer Care - ELLOK

Opportunity to Support the Cancer Drug Parity Act - METAvivor

FDA Approvals
Subcutaneous Isatuximab Multiple Myeloma

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

ESTRO - Evidence Based Radiation Oncology

European Society for Radiotherapy and Oncology (ESTRO)

19 Oct
Radiation Oncology

European Cancer Summit 2026

European Cancer Organisation (ECO)

18 Nov
European Cancer Summit 2026

ESTRO Course: Artificial Intelligence in Radiotherapy Clinical Practice

European Society for Radiotherapy and Oncology (ESTRO)

09 Nov
Artificial Intelligence in Radiotherapy

SPCC Webinar: Real-World AI and Human–AI Collaboration in Oncology

Sharing Progress in Cancer Care (SPCC)

11 Nov
Human–AI Collaboration

SPCC Webinar: Integrative Oncology from Biological Mechanisms to Clinical Impact

Sharing Progress in Cancer Care (SPCC)

28 Oct
Human–AI Collaboration

Immune-oncology
Primary Resistance to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Primary Resistance to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Tumor Microenvironment: Why It Matters for Cancer Immunotherapy

RICE Study: Can Immune Checkpoint Inhibitors Be Used Again After Progression?

KEYNOTE-C93: Pembrolizumab May Replace Chemotherapy in dMMR Endometrial Cancer

NK-Cell Immunotherapy: The Next Frontier in Cancer Treatment

ChemRNA: A New Generation of Simplified RNA Vaccines for Cancer Immunotherapy

10 Must-Read Posts in Immuno-Oncology This Week

Gastrointestinal-Oncology
LUCERNA

LUCERNA Phase 3: Zolbetuximab, Pembrolizumab, and Chemotherapy in CLDN18.2/PD-L1–Positive Gastric/GEJ Cancer

ASCOLT Translational Study and Meta-analysis: Adjuvant Aspirin in Molecularly Selected Colorectal Cancer

Targeting the Primary Tumor in Metastatic Pancreatic Cancer 2026

COMPETE Trial: [177Lu]Lu-Edotreotide Prolongs PFS vs Everolimus in Advanced GEP NETs

Three BOT/BAL Studies in Colorectal Cancer and Sarcoma at ESMO Congress 2026

Could Neoadjuvant Immunotherapy Change the Treatment Pathway for MSS Colon Cancer?

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
CDK4/6

CDK2 Inhibition in CDK4/6 - Resistant Breast Cancer: A New Escape Route Under Study

Gedatolisib Enters ER+ Breast Cancer Care, But the Real Question Is How to Use It

The CDK4/6 Inhibitor Story Is Entering Its Next Chapter in Breast Cancer

High-Risk Node-Negative HR+/HER2− Early Breast Cancer May Carry Recurrence Risk Similar to N1 Disease

Avutometinib Triplet Shows Feasibility After CDK4/6 Inhibitor Progression in HR+/HER2− Metastatic Breast Cancer

Investigator-Assessed PFS May Be Comparable to BICR in HR+/HER2− Metastatic Breast Cancer Trials

ASCO Updates Breast Cancer Follow-Up Guidelines With Risk-Based Surveillance Approach

Lung-Oncology
Zidesamtinib

FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC

Brain-Only Progression in ES-SCLC: When the Brain Progresses, the Systemic Backbone May Still Matter

EGFR Exon 20 and HER2-Deregulated NSCLC: The Rare Lung Cancer Subtypes Moving Into a New Therapeutic Era

EMBER-Lung: A Simple EMR Nudge Nearly Doubled Molecular Testing in Early-Stage NSCLC

Lung Transplant for Lung-Only Stage IV NSCLC: A Bold Idea With Major Caveats

Durvalumab With Radiation Shows Promise in Chemotherapy-Ineligible Locally Advanced NSCLC

Sacituzumab Tirumotecan Plus Pembrolizumab Meets Phase III Endpoint in First-Line PD-L1-Negative Non-Squamous NSCLC

Oncology Tech
Replimune

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

The Thirteen-Minute Infusion: What Sarclisa's Wearable Injector Signals for Cancer Care

Kalshi Launches Sportsbook-Style Markets on Drug Trials and FDA Decisions

After TROP2 and HER2, Is B7-H3 the Next Big ADC Target?

KRAS Grows Up: The Breakthroughs and the Reckonings

Hematology
Leukemia Diagnosis Leukemia symptoms

Leukemia Diagnosis: Every Step From First Symptoms to Treatment and Beyond

Prognostic Scores and Risk Stratification in Myeloproliferative Neoplasms (MPN): 2026 Updates

Chronic Myelomonocytic Leukemia (CMML): Beyond the Overlap, Toward the Bigger Picture

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

ENDURANCE Trial: 2 Years of Lenalidomide Maintenance Matches Continuous Therapy in Standard-Risk Multiple Myeloma

Peripheral T-Cell Lymphomas (PTCL): Another Evolving Lymphoma Story

Europe Opens the Door to Epcoritamab-R² in 2L Follicular Lymphoma: A New Standard?

Radiotherapy
Canada

Mapping Palliative Radiotherapy Access Across Canada

Early Lung Cancer With ILD: SABR and Surgery Remain Curative Options

MR-Guided Radiotherapy Brings Pain Relief in Metastatic Pancreatic Cancer

GammaTile Redefines Postoperative Radiation for Brain Metastases: Lessons from the Phase III ROADS Trial

Life After Anal Cancer: The Hidden Burden of Chemoradiotherapy

Four-Arc Coplanar VMAT Emerges as a Practical Option for Hippocampal-Sparing Whole-Brain Radiotherapy

Unresectable Stage III NSCLC: Precision Redefines Care

OncoDaily TV
World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Rodrigo Sánchez-Bayona open doors

What Makes a Great Oncologist? Insights from Dr. Rodrigo Sánchez-Bayona

Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

ASCO

OncoDaily Highlights from ASCO 2026 Chicago, USA

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Not To Miss
GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

3rd Symposium “Artificial Intelligence in Public Health Research”

2026 IBRI Global Forum on Science, Philanthropy, and Investment

15 Posts Not To Miss From Best of ASCO Africa 2026

Top Growing Medical Universities in Africa: 2026 Edition by BIGR

WHO Calls for Urgent Action as New Cancer Cases Are Projected to Nearly Double by 2050

20 Posts Not To Miss From ESMO GI 2026, Part 2

OncoGrants
Survivorship Award

Breast Cancer Canada and AstraZeneca Canada Advancing Progress in Survivorship Award 2026

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
El Hadji Daouda Niang

El Hadji Daouda Niang

Oncologists Location Dakar, Senegal
Dragana Stanić Tišma

Dragana Stanić Tišma

Oncologists Location Belgrade, Serbia
David Kerr

David Kerr

Oncologists Location
Jackson Orem

Jackson Orem

Oncologists Location Kampala, Uganda
Roshan Daniel

Roshan Daniel

Oncologists Location Thiruvananthapuram, India
Lucia Masarova

Lucia Masarova

Oncologists Location Houston, USA
C.S. Pramesh

C.S. Pramesh

Oncologists Location Mumbai, India
Jia Jenny Liu

Jia (Jenny) Liu

Oncologists Location Sydney, Australia

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports & Case Series